A Pickup in Competition in the U.S. Market Could Be a Lasting Drag

The chief executive of Sanofi reportedly wrote to his board asking directors to dismiss rumors that he could be replaced as boss of the French drug maker. Now, a sudden surge in price competition in the U.S. that casts a pall over the company’s growth prospects isn’t helping his cause.